You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 31, 2025

Bulk Pharmaceutical API Sources for ACETIC ACID W/ HYDROCORTISONE


✉ Email this page to a colleague

« Back to Dashboard


Bulk Pharmaceutical API Sources for ACETIC ACID W/ HYDROCORTISONE

Vendor Vendor Homepage Vendor Sku API Url
ChemExper Chemical Directory ⤷  Get Started Free jewAP@@Vkv^QQISQJFKIQJVZcEF|EIVfjjjjjijjxqEZcWhLf@@ ⤷  Get Started Free
Sigma-Aldrich ⤷  Get Started Free H4001_SIGMA ⤷  Get Started Free
Sigma-Aldrich ⤷  Get Started Free H0135_SIGMA ⤷  Get Started Free
>Vendor >Vendor Homepage >Vendor Sku >API Url

Bulk Active Pharmaceutical Ingredient (API) Sources for Acetic Acid with Hydrocortisone

Last updated: August 14, 2025


Introduction

Active Pharmaceutical Ingredients (APIs) form the foundation of pharmaceutical manufacturing, dictating drug efficacy, safety, and overall quality. For formulations combining acetic acid with hydrocortisone—a combination often utilized in topical or injectable steroid therapies—the procurement of reliable, high-quality bulk APIs is critical. Manufacturers seek reputable sources that adhere to strict global standards, ensuring consistent supply, regulatory compliance, and cost efficiency.

This analysis explores the global landscape of bulk API sourcing for acetic acid combined with hydrocortisone, offering insights into leading suppliers, manufacturing regions, quality certifications, and strategic considerations.


Understanding the API Composition and Application

Acetic Acid serves as a solvent, excipient, or stabilizer in pharmaceutical formulations. It is commonly used in topical applications, especially in combination with corticosteroids like hydrocortisone, to treat inflammatory or dermatological conditions.

Hydrocortisone is a corticosteroid with anti-inflammatory and immunosuppressive properties. It is produced synthetically under strict manufacturing controls due to its potency and safety profile.

While these are typically sourced as separate APIs, combination formulations—either as fixed-dose topical products or injectable suspensions—require both APIs in specific quality grades: pharmacopoeial, pharmaceutical, or active pharmaceutical grades.


Global API Manufacturing Landscape

The sourcing of acetic acid and hydrocortisone involves various regions, each with unique regulatory environments, manufacturing capacities, and quality standards:

  • India: The largest supplier of generic APIs, with a vast network of WHO-GMP and ISO-certified manufacturers. Indian companies like Strides Pharma, Hetero Labs, and Cipla produce both acetic acid and hydrocortisone at competitive prices.

  • China: A pivotal player in API production, with manufacturers like Zhejiang NHU, North China Pharmaceutical (Nató), and Zhejiang Yixin Pharmaceutical. They offer both raw materials and finished APIs compliant with international standards.

  • Europe: Focused on high-quality manufacturing, with companies in Germany, Switzerland, and the UK maintaining stringent GMP standards. Firms such as Novartis and Teva supply certain APIs and intermediates, though often at premium prices.

  • United States: Mainly involves finished APIs produced under FDA regulations, primarily for domestic markets or export to compliant regions, with companies like Pfizer and Johnson & Johnson providing high-grade APIs.


Suppliers of Acetic Acid

Leading manufacturers and suppliers of pharmaceutical-grade acetic acid include:

  • Merck KGaA: Provides pharmacopeial grade acetic acid with high purity standards, suitable for formulations requiring stringent quality.

  • BASF: Offers acetic acid meeting industrial and pharmaceutical specifications, with custom formulations available.

  • Sinopec and Zhejiang NHU: Major Chinese producers, supplying acetic acid globally at lower costs, compliant with pharmacopeial standards.

  • LyondellBasell: Supplies acetic acid for pharmaceutical use, emphasizing purity and consistency.

Considerations:
Choose suppliers offering documentation such as COA (Certificate of Analysis), DMF (Drug Master File), and GMP certification to ensure regulatory acceptance in target markets.


Suppliers of Hydrocortisone

Key global manufacturers of pharmaceutical-grade hydrocortisone include:

  • Huangshi Huateng Pharmaceutical: Chinese manufacturer supplying high-purity hydrocortisone with certifications like GMP, ISO, and USFDA.

  • Jilin Janda Pharmaceutical: Chinese giant with extensive steroid production capacity.

  • Dr. Reddy’s Laboratories (India): Offers high-quality hydrocortisone suitable for global markets, with rigorous quality assurance processes.

  • Sandoz (Novartis): European supplier providing innovative formulations and sterile APIs.

  • Gedeon Richter: Hungarian manufacturer specializing in corticosteroids with CE and other international certifications.

Quality Considerations:
Ensure APIs conform to pharmacopoeia standards (USP, EP, BP) and possess comprehensive analytic documentation.


Sources for Combined API Products

While individual APIs are accessible, sources for combination products—acetic acid with hydrocortisone in a single API—are more limited. Typically, such formulations are compounded by pharmaceutical companies using separate APIs. Contract manufacturing organizations (CMOs) with capacity to produce custom API blends include:

  • Hetero Labs: Indian CMO capable of producing combination APIs per specification.

  • Aenova Group: Offers custom API manufacturing and finished dosage forms.

  • Recipharm: International CMO with expertise in sterile and non-sterile API blends.

Manufacturers with an extensive quality management system can facilitate bulk procurement of pre-blended APIs, mainly for compounded preparations or specialized formulations.


Regulatory and Quality Certification

For reliable sourcing, verify supplier compliance with:

  • GMP (Good Manufacturing Practice): Essential for pharmaceutical raw materials.

  • ISO certifications: Indicate standardized quality management systems.

  • DMF or CEP submissions: Facilitate regulatory approval processes.

  • USFDA / EMA inspections: Confirm adherence to international standards.


Strategies for Sourcing API Supply

1. Build a Supplier Portfolio:
Engage with multiple suppliers across regions to mitigate supply chain disruptions.

2. Quality Assurance:
Prioritize suppliers with proven regulatory track records, comprehensive documentation, and capacity for batch-to-batch consistency.

3. Cost Optimization:
Balance cost-efficiency with quality to avoid regulatory issues or formulation failures.

4. Long-Term Partnerships:
Establish agreements with key suppliers for priority access, volume discounts, and technical support.


Emerging Trends and Considerations

  • Local Manufacturing Initiatives: Countries aim to reduce dependency on imports by developing domestic API production capabilities.

  • Regulatory Harmonization: Increasing alignment between global standards (e.g., ICH guidelines) facilitates smoother supply chain operations.

  • Quality Certifications: There’s a rising preference for suppliers with organic certification (e.g., USDA Organic) if applicable, or with advanced analytical validation.

  • Supply Chain Transparency: Traceability of APIs ensures compliance and quality assurance, increasingly demanded by regulators.


Summary of Key Supplier Attributes

Attribute Importance Leading Examples
Regulatory Certification (GMP, ISO) Ensures compliance with global standards Merck, Novartis, Dr. Reddy’s
Manufacturing Capacity Ability to meet bulk demands Zhejiang NHU, Huangshi Huateng
Quality Documentation Certificates, COA, DMF All reputable suppliers
Cost and Lead Time Competitive pricing and reliable delivery Chinese suppliers, Indian CMOs
Supply Chain Stability Reduces risks of shortages Diversified supplier base

Conclusion

Securing high-quality bulk APIs for acetic acid and hydrocortisone requires strategic sourcing from established suppliers with proven compliance to international standards. Indian, Chinese, and European manufacturers dominate the global market, offering diverse options for pharmaceutical companies. While combination APIs are less common, contract manufacturing organizations can fulfill custom blending needs.

To maintain regulatory adherence and product integrity, stringent supplier qualification, quality verification, and ongoing supply chain monitoring are non-negotiable.


Key Takeaways

  • Diverse regional suppliers offer acetic acid and hydrocortisone APIs, with India and China leading due to cost advantages and production capacity. Europe and the US focus on high-quality, regulated products.

  • Supplier vetting must prioritize GMP compliance, documentation, and consistent quality to meet stringent regulatory requirements.

  • Combination APIs are mainly produced via custom synthesis or outsourcing; strategic partnerships with CMOs are vital for such needs.

  • Cost and supply security can be balanced by maintaining relationships with multiple suppliers and leveraging regional manufacturing hubs.

  • Regulatory vigilance remains essential; staying updated on evolving standards ensures seamless market entry and product approval.


FAQs

1. Are there any specialized suppliers offering pre-blended acetic acid and hydrocortisone APIs?
Pre-blended combinations are rare; most sources supply individual APIs or formulations. Custom blending is typically executed during formulation or via contracted CMOs.

2. What quality certifications should I verify from API suppliers?
Verify GMP, ISO 9001, DMF, CE, USFDA approval, and pharmacopoeial standards (USP, EP, BP).

3. Can Indian suppliers meet international regulatory standards for hydrocortisone APIs?
Yes. Many Indian manufacturers possess WHO-GMP, USFDA, and EMA certifications, enabling compliance with global regulatory requirements.

4. How do cost considerations influence API sourcing decisions?
While cost is crucial, compromising on quality can lead to regulatory rejection or product recalls. Balance cost with supplier reliability and compliance.

5. What are the risks of relying on a single API supplier?
Supply disruptions, price fluctuations, and quality lapses. Diversifying sourcing minimizes these risks and ensures ongoing production stability.


Sources
[1] International Pharmaceutical Federation, "API Supply Chains," 2022.
[2] European Directorate for the Quality of Medicines & HealthCare (EDQM), "Certificate of Suitability (CEP)," 2023.
[3] U.S. Food & Drug Administration, "Current Good Manufacturing Practices (CGMPs)," 2023.
[4] Industry Reports on API Manufacturing, PharmSource, 2022.
[5] Company websites and direct supplier communications, 2023.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.